Coop Kevin 4
4 · Definitive Healthcare Corp. · Filed Feb 26, 2026
Research Summary
AI-generated summary of this filing
Definitive Healthcare (DH) CEO Kevin Coop Receives 1.735M RSU Award
What Happened
Kevin Coop, CEO of Definitive Healthcare (ticker: DH), was granted 1,735,437 restricted stock units (RSUs) on February 24, 2026, reported on a Form 4 filed Feb 26, 2026. The filing reports an acquisition amount of $0.00, which reflects that these are time‑based RSU awards (not an open‑market purchase). The RSUs represent a contingent right to receive one share of Class A common stock upon vesting.
Key Details
- Transaction date: 2026-02-24; Form 4 filed: 2026-02-26.
- Transaction type/code: Award/Grant (A). Reported acquisition price: $0.00.
- Shares granted: 1,735,437 RSUs. Reported total value is $0 on the Form 4 (typical for RSU grants).
- Shares owned after the transaction: not specified in the filing provided.
- Footnote (F1): These RSUs vest 25% on March 1, 2027, then 6.25% every three months thereafter over the following three years (totaling the remaining 75%), contingent on continued service.
Context
RSUs are a form of equity compensation that convert into actual shares only as they vest; they are not an immediate market purchase or sale. Such grants are commonly used for executive compensation and retention; they do not by themselves indicate immediate buying or selling intent in the market.
Insider Transaction Report
- Award
Class A Common Stock
[F1]2026-02-24+1,735,437→ 5,291,989 total
Footnotes (1)
- [F1]Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001, with 25% of the RSUs vesting on March 1, 2027, followed by vesting of 6.25% every three months thereafter over the subsequent three years, subject to the Reporting Person's continued service with the Issuer through each such vesting date.